Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Proportion of distant-stage cases higher among black males than among white males.
»
02/22/17
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.
Combination of HDAC and MAPK inhibitors may play role in treatment of melanoma.
»
06/15/17
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Twelve weeks' treatment with anamorelin was safe.
»
06/19/17
Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
Increase related to factors that promote early diagnosis of low-risk lesions.
»
05/05/17
Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.
Both characterized by aberrant RAS pathway.
»
08/15/17
Knockdown of Trio by CRISPR/Cas9 suppresses migration and invasion of cervical cancer cells.
Trio may regulate through RhoA/ROCK signaling pathway.
»
07/27/17
Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
Association between EDIP and colorectal cancer risk significant.
»
01/13/17
Biomarkers of primary resistance to trastuzumab in HER2-positive metastatic gastric cancer patients: the AMNESIA case-control study.
Predictive accuracy of combined evaluation of AMNESIA panel and HER2 IHC 84%.
»
11/30/17
Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
ANXA3 expression higher in basal subtype of breast cancer cells.
»
08/04/17
Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: a Two-Center Prospective Study.
Urinary methylation of miRNA genes may be a useful marker.
»
08/27/17
< Prev
Next >